Biofilm: Its Relevance In Kidney Disease

Advances in Chronic Kidney Disease

Volumn 13, Issue 3, 2006, Pages 215-224

  Tapia, Gino ^a   Yee, Jerry ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Acylhomoserine lactones; Autoinducer; Biofilm; Chronic kidney disease; End stage renal disease; Quorum sensing

Indexed keywords

ALTEPLASE; ANTIINFECTIVE AGENT; BACTERICIDE; CLINDAMYCIN; EDETATE SODIUM; ERYTHROMYCIN; EXOPOLYSACCHARIDE; FIBRINOLYTIC AGENT; FURANONE DERIVATIVE; GENTAMICIN; LINEZOLID; MINOCYCLINE; PISUM SATIVUM EXTRACT; PLANT EXTRACT; RIFAMPICIN; STREPTOKINASE; SURFACTANT; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; BIOFOULING; CARDIOVASCULAR RISK; CATHETER; CATHETER INFECTION; CATHETERIZATION; CAUSE OF DEATH; CHRONIC INFLAMMATION; COLONY FORMATION; COLONY FORMING UNIT; DEVICE INFECTION; DISINFECTION; ELECTRIC CURRENT; GENE EXPRESSION; HEMODIALYSIS; HUMAN; HYGIENE; INFECTION RISK; INFLAMMATION; KIDNEY DISEASE; LEACHING; LUNG INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COLONIZATION; NEPHROLITHIASIS; NONHUMAN; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; TISSUE INJURY; URINARY TRACT INFECTION; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; WATER CONTAMINATION; WATER SUPPLY;

BIOFILMS; CATHETERS, INDWELLING; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; RISK FACTORS;

EID: 33745399381     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2006.04.002     Document Type: Article

References (68)

1. Costerton J.W. Bacterial biofilms. A common cause of persistent infections. Science 284 (1999) 1318-1322
2. Haley R.W. Incidence and nature of endemic and epidemic nosocomial infections. In: Brachman P. (Ed). Hospital Infections (1985), Little Brown, Boston, MA 359-374
3. Engemann J.J., Friedman J.Y., Reed S.D., et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26 (2005) 534-539
4. Choong S., and Whitfield H. Biofilms and their role in infections in urology. BJU Int 86 (2000) 935-941
5. Meng Y., Li Y., Galvani C.D., et al. Upstream migration of Xylella fastidiosa via pilus-driven twitching motility. J Bacteriol 187 (2005) 5560-5567
6. Fujishige N.A., Kapadia N.N., and Hirsch A.M. Feeling for the micro-organism: Structure on a small scale. Biofilms on plant roots. Bot J Linn Soc 150 (2006) 79-88
7. Anwar H., Dasgupta M.K., and Costerton J.W. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 34 (1990) 2043-2046
8. Lowy F. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
9. Balaban N., Goldkorn T., Gov Y., et al. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J Biol Chem 276 (2001) 2658-2667
10. Schauder S., and Bassler B.L. The languages of bacteria. Genes Dev 15 (2001) 1468-1480
11. Ishani A., Collins A., Herzog C., et al. Septicemia, access and cardiovascular disease in dialysis patients. The USRDS Wave 2 Study. Kidney Int 68 (2005) 311-318
12. Nickel J.C., Reid G., Bruce A., et al. Ultrastructural microbiology of infected urinary stone. Urology 28 (1986) 512-515
13. McLean R.J., Lawrence J.R., Korber D.R., et al. Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. J Urol 146 (1991) 1138-1142
14. Nickel J.C. Prostatitis. In: Mulholland S.G. (Ed). Antibiotic Therapy in Urology (1996), Lippincott-Raven, Philadelphia, PA 5-62
15. Nassar G., and Ayus J.C. Infectious complications of the hemodialysis access. Kidney Int 60 (2001) 1-13
16. Arduino M.J., and Tokars J.I. Why is an infection control program needed in the hemodialysis setting?. Nephrol News Issues 19 44 (2005) 46-49
17. Khardori N., and Yassien M. Biofilms in device-related infections devices. J Ind Microbiol 3 (1995) 141-147
18. Maraj S., Jacobs L.E., Maraj R., et al. Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci 327 (2004) 242-249
19. Costerton W., Veeh R., Shirtliff M., et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112 (2003) 1466-1477
20. Finkelstein E.S., Jekel J., Troidle L., et al. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 39 (2002) 1278-1286
21. Raad I.I., Costerton W., Sabharwal U., et al. Ultrastructural analysis of indwelling vascular catheters. A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
22. Cappelli G., Tetta C., and Canaud B. Is biofilm a cause of silent chronic inflammation in hemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant 20 (2005) 266-270
23. Thodis E., and Passadakis P. Peritoneal catheters and related infections. Int Urol Nephrol 37 (2005) 379-393
24. Gorman S.P., Adair C.G., and Mawhinney W.M. Incidence and nature of peritoneal catheter biofilm determined by electron and confocal laser scanning microscopy. Epidemiol Infect 112 (1994) 551-559
25. Duch J., and Yee J. Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis 37 (2001) 149-153
26. Man N.K., Degremont A., Derbord J.C., et al. Evidence of bacterial biofilm in tubing from hydraulic pathway of hemodialysis system. Artif Organs 22 (1998) 596-600
27. Cappelli G., Ballestri M., Perrone S., et al. Biofilms invade nephrology. Effects in hemodialysis. Blood Purif 18 (2000) 224-230
28. Cappelli G., Ravera F., Ricardi M., et al. Water treatment for hemodialysis. A 2005 update. Contrib Nephrol 149 (2005) 42-50
29. Marion-Ferey K., Enkiri F., Pasmore M., et al. Methods for biofilm analysis on silicone tubing of dialysis machines. Artif Organs 27 (2003) 658-664
30. Stewart P.S., and Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 358 (2001) 135-138
31. Cappelli G. Effects of biofilm formation on hemodialysis monitor disinfection. Nephrol Dial Transplant 18 (2003) 2105-2111
32. Canaud B., Senecal L., Leray-Moragues H., et al. Vascular access, an underestimated cause of inflammation in hemodialysis patient. Nephrologie 24 (2003) 353-358
33. Tricia L., Obrador G., St. Peter W., et al. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int 66 (2004) 2429-2436
34. Marion F.K., Enkiri F., Pasmore M., et al. Methods for biofilm analysis on silicone tubing of dialysis machines. Artif Organs 27 (2003) 658-664
35. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 70 (2005) 267-274
36. Roberts A.P., Pratten J., Wilson M., et al. Transfer of a conjugative transposon, Tn5397 in a model oral biofilm. FEMS Microbiol Lett 177 (1999) 636
37. Hausner M., and Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 65 (1999) 3710-3713
38. Donlan RM: Biofilms: microbial life on surfaces. Emerg Infect Dis [serial online], 2002 Sep [date cited]. Available at: http://www.cdc.gov/ncidod/EID/vol8no9/02-0063.htm. Accessed March 7, 2006.
39. Vandenesch F., Naimi T.S., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes. Worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
40. Turabelidze G, Lin M, Wolkoff B, et al: Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis [serial on the Internet]. 2006 Mar [date cited]. Available at: http://www.cdc.gov/ncidod/EID/vol12no03/05-0625.htm. Accessed February 27, 2006.
41. Smeets E., Kooman J., van der Sande F., et al. Prevention of biofilm formation in dialysis water treatment systems. Kidney Int 63 (2003) 1574-1576
42. Ledebo I., and Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs 23 (1999) 37-43
43. Canaud B. Hemodialysis catheter-related infection. time for action. Nephrol Dial Transplant 14 (1999) 2288-2290
44. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 (2000) 391-402
45. Holmes C.J., Degremont A., Kubey W., et al. Effectiveness of various chemical disinfectants versus cleaning combined with heat disinfection on Pseudomonas biofilm in hemodialysis machines. Blood Purif 22 (2004) 461-468
46. Marion K., Pasmore J., Freney E., et al. A new procedure allowing the complete removal and prevention of hemodialysis biofilms. Blood Purif 23 (2005) 339-348
47. Raad I., Darouiche R., Dupuis J., et al., The Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 127 (1997) 267-274
48. Maki D., Stolz S., Wheeler S., et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127 (1997) 257-266
49. Crabtree J.H., Burchette R.J., Sidiqqi R.A., et al. The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial Int 23 (2003) 368-374
50. Curtin J., Cormican M., Fleming G., et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47 (2003) 3145-3148
51. Kite P., Eastwood K., Sugden S., et al. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42 (2004) 3073-3076
52. Percival S.L., Kite P., Eastwood K., et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26 (2005) 515-519
53. Sofer D., Gilboa-Garber N., Belz A., et al. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 45 (1999) 335-341
54. Herbert S., Barry P., Novick R., et al. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 69 (2001) 2996-3003
55. Balaban N., Giacometti A., Cirioni O., et al. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 187 (2003) 625-630
56. Dell'Acqua G., Giacometti A., Cirioni O., et al. Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 190 (2004) 318-320
57. Trautner B.W., Darouiche R.O., Hull R.A., et al. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 167 (2002) 375-379
58. Trautner B.W., Hull R.A., and Darouiche R.O. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 61 (2003) 1059-1062
59. Trautner B.W., Hull R.A., and Darouiche R.O. Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis 18 (2005) 37-41
60. Cha C., Gao P., Chen Y.C., et al. Production of acyl-homoserine lactone quorum-sensing signals by gram-negative plant-associated bacteria. Mol Plant Microbe Interact 11 (1998) 1119-1129
61. Teplitski M., Robinson J.B., and Bauer W.D. Plants secrete substances that mimic bacterial N-acyl homoserine lactone signal activities and affect population density-dependent behaviors in associated bacteria. Mol Plant Microbe Interact 13 (2000) 637-648
62. Hentzer M., Riedel K., Rasmussen T.B., et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148 (2002) 87-102
63. Rediske A.M., Hymas W.C., Wilkinson R., et al. Ultrasonic enhancement of antibiotic action on several species of bacteria. J Gen Appl Microbiol 44 (1998) 283-288
64. Wellman N., Fortune S.M., and McLeod B.R. Bacterial biofilms and the bioelectric effect. Antimicrob Agents Chemother 40 (1996) 2012-2014
65. Costerton J.W., Ellis B., Lam K., et al. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 38 (1994) 2803-2809
66. Ehrlich G.D., Stoodley P., Kathju S., et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res 437 (2005) 59-66
67. Splendiani A., Livingston A.G., and Nicolella C. Control of membrane-attached biofilms using surfactants. Biotechnol Bioeng 94 (2006) 15-23
68. Yoon S.S., Coakley R., Lau G.W., et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116 (2006) 436-446